Outlook Therapeutics
OTLK
#8491
Rank
โ‚ฌ0.12 B
Marketcap
5,23ย โ‚ฌ
Share price
-7.55%
Change (1 day)
-36.38%
Change (1 year)

Earnings for Outlook Therapeutics (OTLK)

Earnings in 2024 (TTM): -โ‚ฌ86.78 Million

According to Outlook Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚ฌ48.89 Million, an increase over its 2022 earnings that were of -โ‚ฌ66.7 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Outlook Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ86.78 Million77.5%
2023 -โ‚ฌ48.89 Million-26.7%
2022 -โ‚ฌ66.7 Million32.13%
2021 -โ‚ฌ50.48 Million46.21%
2020 -โ‚ฌ34.53 Million-18.82%
2019 -โ‚ฌ42.53 Million16.62%
2018 -โ‚ฌ36.47 Million57.88%
2017 -โ‚ฌ23.1 Million-56.17%
2016 -โ‚ฌ52.7 Million-9.26%
2015 -โ‚ฌ58.08 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.11 Billion 21.71% Jersey
-โ‚ฌ0.26 Billion 190.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ13.28 Million-85.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ69.37 Million-22.31%๐Ÿ‡ฌ๐Ÿ‡ง UK